Part D/Prescription Drugs – Page 93

Friday, September 11, 2026

Latest:

What to make of the AstraZeneca vaccine data — and the surrounding controversy

(By Adam Feurerstein, Damian Garde, and Meg Tirrell for ST A T) AstraZeneca’s up-and-down quest to develop a vaccine for

(By Maia Anderson for Becker’s Hospital Review ) Pharmaceutical companies have seen a sharp increase in positive public opinion over

(By Wyatt Koma, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation published March 23, 2021) More than 62 million

(By Maia Anderson for Becker’s Hospital Review ) The best-selling drug in the world in 2020 was AbbVie’s Humira, an

(By Alia Paavola for Becker’s Hospital Review ) CMS has been quietly reviewing several of its payment models to decide

(By Andrew Joseph for ST A T) U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced

(By Emmarie Huetteman for Kaiser Health News) Democrats, newly in control of Congress and the White House, are united behind

(By Bernard J. Wolfson for Kaiser Health News) As you surely know, this country’s covid vaccination effort has been plagued

(By Maia Anderson for Becker’s Hospital Review ) Eleven children’s hospitals and startup drugmaker Phlow have joined forces to create

The U.S. District Court for the District of Columbia has issued a court order delaying the Department of Health and